
Supportive Care
Latest News
Advertisement
Video Series
Latest Videos
CME Content
Advertisement
More News













Refaat Hegazi, MD, PhD, MPH, discusses nutrition-related toxicities in oncology.

The advent of immunotherapy options to treat patients with cancer has brought with it a new wave of immuno-related toxicities. One institution, Massachusetts General Hospital, has taken steps to establish an immunotherapy toxicity service care team, inspired by a 65-year-old patient with metastatic melanoma that had spread to his lungs and brain.

Cardiac resynchronization therapy improved heart function in patients who developed chemotherapy-induced cardiomyopathy.

The FDA has accepted a biologics license application to review eflapegrastim for the management of chemotherapy-induced neutropenia.









Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5


























































